Jun 24, 2018 | In The News, Technology Updates
FDA Approves World’s First Long-Term Implantable Continuous Glucose Monitoring System for Marketing in United States was announced by Senseonics, 21 June 2018. Senseonics Holdings, Inc. (NYSE American: SENS) today announced the U.S. Food and Drug...
May 4, 2018 | Featured, Technology Updates
VOTE for your FAVORITE or MOST EXCITING INNOVATIONS!!! Finalists Announced for 2018 Diabetes Innovation Challenge Winners of $250,000 in Cash and In-Kind Prizes to be Announced at Live Event in Boston May 21, 2018. BOSTON, April 24, 2018 (GLOBE NEWSWIRE)...
Apr 29, 2018 | Featured, Technology Updates
A 90-Day CGM? FDA Panel Votes in Favor of Senseonics’ Eversense, all about the FDA recommendation for the 90-day implantable CGM, was reported by Ben Pallant, Maeve Serino and Adam Brown on diaTribe.com, 12 April, 2018. On March 29, an advisory panel recommended...
Apr 8, 2018 | Featured, Research News, Technology Updates
Eli Lilly ponies up $63M for Sigilon’s diabetes cell therapies, according to Amirah Al Adrus of FierceBiotech.com, 4 April 2018. Eli Lilly is continuing its push into new diabetes products, paying $63 million up front to get its hands on Sigilon Therapeutics’...
Mar 29, 2018 | Featured, Technology Updates
Dexcom G6 cleared by FDA with no fingerstick calibrations 10-day wear time approval for ages 2 years and older no acetaminophen interference and more The FDA just cleared the Dexcom G6 CGM today, only six months after it was submitted to the FDA and far earlier...
Feb 1, 2018 | Featured, Technology Updates
Big Money in Diabetes Devices! Bigfoot raises $37M to trial AI-enabled insulin delivery devices Beta Bionics takes step toward $25M financing round Chinese buyers mull bids for Johnson & Johnson’s $4B diabetes unit Dermapace System stimulates wound...